Avisi Technologies
Avisi Technologies is a clinical-stage medical device company dedicated to advancing vision care through innovative ophthalmic solutions. They are developing state-of-the-art treatments for glaucoma and other ocular conditions, including their flagship VisiPlate® aqueous shunt, a sustained drug delivery platform, and a device to treat mild glaucoma. Their mission is to restore health and promote vitality by creating accessible and cutting-edge healthcare solutions, with a focus on minimally-invasive treatments and nanotechnology-enabled devices.
Industries
Nr. of Employees
small (1-50)
Avisi Technologies
Products
Ultrathin multichannel aqueous shunt (investigational)
An investigational ultrathin implant composed of metamaterial layers with interconnected microchannels designed to wick and drain aqueous humor to a secondary drainage zone to lower intraocular pressure.
Sustained ocular drug delivery platform (investigational)
A platform under development intended to enable sustained intraocular drug delivery to complement implantable glaucoma treatments.
Device for treatment of mild glaucoma (investigational)
A pipeline device concept intended to address mild forms of glaucoma as part of the development portfolio.
Ultrathin multichannel aqueous shunt (investigational)
An investigational ultrathin implant composed of metamaterial layers with interconnected microchannels designed to wick and drain aqueous humor to a secondary drainage zone to lower intraocular pressure.
Sustained ocular drug delivery platform (investigational)
A platform under development intended to enable sustained intraocular drug delivery to complement implantable glaucoma treatments.
Device for treatment of mild glaucoma (investigational)
A pipeline device concept intended to address mild forms of glaucoma as part of the development portfolio.
Expertise Areas
- Clinical trial management for early‑stage devices
- Ophthalmic implant research and development
- Microfabrication and MEMS-based manufacturing
- Biomaterials for implantable devices and anti‑fibrotic strategies
Key Technologies
- Nanofabrication and metamaterials for implants
- MEMS microfabrication
- Medical‑grade polymer and inorganic thin‑film combinations for implants
- Multichannel microfluidic network design